Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report) shares traded down 1.9% during mid-day trading on Monday . The stock traded as low as GBX 26 ($0.33) and last traded at GBX 26.50 ($0.33). 49,264 shares traded hands during trading, a decline of 85% from the average session volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.34).
Mereo BioPharma Group plc (MPH.L) Stock Down 1.9 %
The company’s 50-day moving average is GBX 26.50 and its 200 day moving average is GBX 26.50. The stock has a market capitalization of £89.76 million and a PE ratio of -0.21. The company has a current ratio of 2.98, a quick ratio of 2.92 and a debt-to-equity ratio of 164.26.
Mereo BioPharma Group plc (MPH.L) Company Profile
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Featured Stories
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
